160 related articles for article (PubMed ID: 37626292)
1. Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial.
Dawoud M; Al-Husseiny M; Helal O; Elsherbini M; Abdel-Rasheed M; Sediek M
BMC Pregnancy Childbirth; 2023 Aug; 23(1):611. PubMed ID: 37626292
[TBL] [Abstract][Full Text] [Related]
2. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.
Chaudhuri P; Majumdar A
Int J Gynaecol Obstet; 2015 Jan; 128(1):48-52. PubMed ID: 25277789
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: A double-blind placebo randomized controlled trial.
Ortuanya KE; Eleje GU; Ezugwu FO; Odugu BU; Ikechebelu JI; Ugwu EO; Eke AC; Awkadigwe FI; Ezenwaeze MN; Ofor IJ; Okafor CC; Okafor CG
Womens Health (Lond); 2024; 20():17455057231225311. PubMed ID: 38279808
[TBL] [Abstract][Full Text] [Related]
4. The effect of intrauterine misoprostol on blood loss during caesarean section.
Bahadur A; Khoiwal K; Bhattacharya N; Chaturvedi J; Kumari R
J Obstet Gynaecol; 2019 Aug; 39(6):753-756. PubMed ID: 31010345
[TBL] [Abstract][Full Text] [Related]
5. Comparative study between oxytocin and combination of tranexamic acid and ethamsylate in reducing intra-operative bleeding during emergency and elective cesarean section after 38 weeks of normal pregnancy.
Bosilah AH; Eldesouky E; Alghazaly MM; Farag E; Sultan EEK; Alazazy H; Mohamed A; Ali SMS; Elsror AGA; Mahmoud M; Abd Elhalim AEM; Kamel MA; Abd-ElGawad M; Sayed FM; Bakry MS
BMC Pregnancy Childbirth; 2023 Jun; 23(1):433. PubMed ID: 37308871
[TBL] [Abstract][Full Text] [Related]
6. Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial.
Othman ER; Fayez MF; El Aal DE; El-Dine Mohamed HS; Abbas AM; Ali MK
Taiwan J Obstet Gynecol; 2016 Dec; 55(6):791-795. PubMed ID: 28040121
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized controlled trial to explore oral tranexamic acid as adjunct for the treatment for postpartum hemorrhage.
Diop A; Abbas D; Ngoc NTN; Martin R; Razafi A; Tuyet HTD; Winikoff B
Reprod Health; 2020 Mar; 17(1):34. PubMed ID: 32143721
[TBL] [Abstract][Full Text] [Related]
8. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
[TBL] [Abstract][Full Text] [Related]
9. Sublingual misoprostol to decrease blood loss after caesarean delivery: a randomised controlled trial.
Ugwu IA; Enabor OO; Adeyemi AB; Lawal OO; Oladokun A; Olayemi O
J Obstet Gynaecol; 2014 Jul; 34(5):407-11. PubMed ID: 24724983
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of intrauterine misoprostol during cesarean section in prevention of primary PPH, a randomized controlled trial.
Alalfy M; Lasheen Y; Elshenoufy H; Elzahaby IM; Kaleem HW; El Sawah H; Azkalani A; Saber W; Rashwan ASSA
J Matern Fetal Neonatal Med; 2020 May; 33(9):1459-1465. PubMed ID: 30176758
[No Abstract] [Full Text] [Related]
11. A randomised controlled trial of tranexamic acid versus misoprostol in reducing blood loss during caesarean section.
Ogah CO; Anikwe CC; Ikeoha CC; Dimejesi OB; Okorochukwu BC; Esike CO
Ghana Med J; 2022 Jun; 56(2):55-63. PubMed ID: 37449262
[TBL] [Abstract][Full Text] [Related]
12. Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study.
Elgafor el Sharkwy IA
Arch Gynecol Obstet; 2013 Dec; 288(6):1231-6. PubMed ID: 23689739
[TBL] [Abstract][Full Text] [Related]
13. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.
Chaudhuri P; Mandi S; Mazumdar A
J Obstet Gynaecol Res; 2014 Sep; 40(9):2023-30. PubMed ID: 25181622
[TBL] [Abstract][Full Text] [Related]
14. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
Vimala N; Mittal S; Kumar S
Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of preoperative tranexamic acid in reducing blood loss during caesarean section at Aminu Kano Teaching Hospital, Kano: a randomized controlled trial.
Oseni RO; Zakari M; Adamou N; Umar UA
Pan Afr Med J; 2021; 39():34. PubMed ID: 34422157
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid, as an adjunct to oxytocin prophylaxis, in the prevention of postpartum haemorrhage in women undergoing elective caesarean section: A single-centre double-blind randomised controlled trial.
Lee SH; Kwek ME; Tagore S; Wright A; Ku CW; Teong ACA; Tan AWM; Lim SWC; Yen DYT; Ang CYX; Sultana R; Lim CHF; Mathur D; Mathur M
BJOG; 2023 Aug; 130(9):1007-1015. PubMed ID: 36852501
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of carbetocin and oxytocin efficacy in prevention of postpartum hemorrhage in women after cesarean section].
Jagielska I; Kazdepka-Ziemińska A; Kaczorowska A; Madej A; Kolossa T; Grabiec M
Ginekol Pol; 2015 Sep; 86(9):689-93. PubMed ID: 26665571
[TBL] [Abstract][Full Text] [Related]
18. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.
Owonikoko KM; Arowojolu AO; Okunlola MA
J Obstet Gynaecol Res; 2011 Jul; 37(7):715-21. PubMed ID: 21375669
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial.
Abdel-Aleem H; Alhusaini TK; Abdel-Aleem MA; Menoufy M; Gülmezoglu AM
J Matern Fetal Neonatal Med; 2013 Nov; 26(17):1705-9. PubMed ID: 23574458
[TBL] [Abstract][Full Text] [Related]
20. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis.
Parry Smith WR; Papadopoulou A; Thomas E; Tobias A; Price MJ; Meher S; Alfirevic Z; Weeks AD; Hofmeyr GJ; Gülmezoglu AM; Widmer M; Oladapo OT; Vogel JP; Althabe F; Coomarasamy A; Gallos ID
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012754. PubMed ID: 33232518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]